Portola Pharmaceuticals LLC - Company Profile

Powered by

All the sales intelligence you need on Portola Pharmaceuticals LLC in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Portola Pharmaceuticals LLC fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Portola Pharmaceuticals LLC.

Back to companies

Portola Pharmaceuticals LLC: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Portola Pharmaceuticals LLC is developing therapeutics for the treatment of liver transplant rejection and allergic conjunctivitis. The company is headquartered in South San Francisco, California, the US.

 Gain a 360-degree view of Portola Pharmaceuticals LLC and make more informed decisions for your business Gain a 360-degree view of Portola Pharmaceuticals LLC and make more informed decisions for your business Learn more
Headquarters United States of America
Address 270 East Grand Avenue, San Francisco, California, 94080
No of Employees 408
Industry Pharmaceuticals and Healthcare
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Portola Pharmaceuticals LLC premium industry data and analytics

50+

Clinical Trials

Determine Portola Pharmaceuticals LLC go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

14+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

12+

Pipeline Drugs

Identify which of Portola Pharmaceuticals LLC’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

4

Catalyst Calendar

Proactively evaluate Portola Pharmaceuticals LLC’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

3

Sales & Consensus Forecasts

Understand the current and future drug revenue for Portola Pharmaceuticals LLC and assess market opportunity for new entrants with patient population 8-year forecasts.

2

Marketed Drugs

Understand Portola Pharmaceuticals LLC’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Portola Pharmaceuticals LLC’s likely spend across technology areas enabling you to understand the digital strategy.

Image for loader

Competitor Comparison

Key Parameters Portola Pharmaceuticals LLC Xencor Inc Zevra Therapeutics Inc Rocket Pharmaceuticals Inc SELLAS Life Sciences Group Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City San Francisco Pasadena Celebration Cranbury New York City
State/Province California California Florida New Jersey New York
No. of Employees 408 260 61 202 15
Entity Type Private Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Portola Pharmaceuticals LLC key executives to enhance your sales strategy Gain insight into Portola Pharmaceuticals LLC key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?